Image Trademark with Serial Number 88779673![Image for trademark with serial number 88779673](/media/image.php?serial=88779673)
Status: 700 - Registered
Serial Number
88779673
Registration Number
6135446
Status
700 - Registered
Status Date
2020-08-25
Filing Date
2020-01-30
Registration Number
6135446
Registration Date
2020-08-25
Mark Drawing
2000 - Illustration: Drawing or design without any word(s)/letter(s)/ number(s)
Typeset
Design Searches
021107, 021115, 250304, 260111, 260121, 260131 - Hands, fingers and arms. Imprints of hands; fingerprints. Backgrounds covered with circles or ellipses. Letters, numerals, punctuation, geometric figures, objects, humans, plants or animals comprising a circle. Circles that are totally or partially shaded. Five or more circles.
Published for Opposition Date
2020-06-09
Attorney Name
Law Office Assigned Location Code
M40
Employee Name
COUGHLAN, REBECCA D.
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of a series of circular shapes that form a larger circle having the outline of a hand at the center.
Goods and Services
Research and development of pharmaceuticals, therapeutics, and biologics, namely, vaccines, acellular vaccines, protein-based vaccines, conjugated vaccines, and vaccines generated in an in vitro cell-free expression system; Research and development in the field of bioinformatics and production of proteins in cell-free expression systems for the development of vaccines; Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; research and development of new drug compounds for therapeutic use, namely, new vaccines for therapeutic use; Research and development of pharmaceuticals, therapeutics, and biologics for the treatment of viral infection, bacterial infection, fungal infection, and parasitic infestation; Research and development in the field of biosynthetic pathways involved in response to viral infection, bacterial infection, fungal infection, and parasitic infestation; Research and development in the field of biosynthetic pathways and their evolution in response to viral infection, bacterial infection, fungal infection, and parasitic infestation; Research and development in the fields of bioinformatic-derived drug discovery; Research and development of software-based platforms for the identification of novel therapeutic drug compounds, namely, software-based platforms for collecting, identifying, and searching collections of natural products and biosynthesis pathways and generating a drug compound database that allows for structure guided searching to identify new therapeutic drug candidates; Services in the field of therapeutic drug discovery, namely, providing temporary use of online non-downloadable data processing software services, in the fields of pharmaceutical, biomedical, medical and clinical research and drug discovery; Services in the field of therapeutic drug discovery, namely, providing temporary use of online non-downloadable software services for the identification of novel therapeutic drug compounds, namely, providing temporary use of online non-downloadable software services for collecting, identifying, and searching collections of the biosynthetic pathways and their products and generating a drug compound database that allows for structure guided searching to identify new therapeutic drug candidates; Research and development of pharmaceuticals, therapeutics, and biologics, namely, toxins for therapeutic use, protein- based toxins for therapeutic use, protein-based toxins generated in an in vitro cell-free expression system for therapeutic and medical research uses; Research and development in the field of bioinformatics and production of protein-based toxins having therapeutic applications; Research and development of new toxin compounds for therapeutic use, namely, new protein-based toxins for therapeutic use; Research and development of pharmaceuticals, therapeutics, and biologics, namely, toxins for diagnostic use, protein-based toxins for diagnostic use, protein-based toxins generated in an in vitro cell-free expression system for diagnostic and medical research uses
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-02-05
Primary Code
042
First Use Anywhere Date
2019-11-25
First Use In Commerce Date
2019-11-25
Current Trademark Owners
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
DAVID S. KERR
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2020-02-03 | NEW APPLICATION ENTERED IN TRAM |
2020-02-05 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-02-06 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2020-04-20 | ASSIGNED TO EXAMINER |
2020-04-22 | EXAMINERS AMENDMENT -WRITTEN |
2020-04-22 | EXAMINERS AMENDMENT E-MAILED |
2020-04-22 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2020-04-22 | EXAMINER'S AMENDMENT ENTERED |
2020-04-27 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-05-05 | ASSIGNED TO LIE |
2020-05-20 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-06-09 | PUBLISHED FOR OPPOSITION |
2020-06-09 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-08-25 | REGISTERED-PRINCIPAL REGISTER |
2020-12-09 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |